Panacea Biotec Ltd (PANACEABIO) — FY26 Annual Report | 7 September 2026

7 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

New independent director appointed and AGM scheduled for September 29, 2026

🔄 What Changed

New independent director appointed; AGM date set; electronic report distribution confirmed

🔮 What's Next

AGM to be held on September 29, 2026 at 11:30 A.M. IST via video conferencing

💡 Investor Takeaway

Shareholding remains concentrated with promoters at 72.48%, and 99.76% of shares are dematerialized

Panacea Biotec Ltd's 2025-26 Annual Report details governance updates including a new independent director, AGM scheduled for September 29, 2026 via video conference, and electronic-only report distribution. The company maintains going concern status amid vaccine-related awards from UNICEF and PAHO, with provisions for impairments and bad debts totaling ₹674.99 million. It resolved an Apotex arbitration for $5 million while facing ongoing disputes with HV and Generium. Shareholding remains highly concentrated with promoters at 72.48%, and 99.76% of shares are dematerialized. No material changes or frauds were reported, though minor statutory filing delays occurred.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PANACEABIO ✨ Ask AI About This

About Panacea Biotec Ltd (PANACEABIO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹2,252.5 CrROE: -0.8%ROCE: -0.5%

View full PANACEABIO stock details →

📡 Get AI alerts when PANACEABIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PANACEABIO — Free

💡 Ask AI about this filing

"What is the expected timeline for resolving the HV arbitration case?""How will the UNICEF and PAHO awards impact future revenue streams?""What is the status of the pending Generium arbitration dispute?"

Ask AI Free →

📊 More PANACEABIO filings

🔴 Announcement — 29 September 2026Panacea Biotec disclosed two Income Tax demand orders dated September 28, 2026, imposing a combined ...
Announcement — 26 September 2026Panacea Biotec announced that its trading window will close on October 1, 2026, for all designated p...
Announcement — 26 September 2026Panacea Biotec disclosed receipt of four income tax demand orders from Delhi's Assistant Commissione...
share transfer — 15 September 2026Panacea Biotec sent reminder letters to physical shareholders on September 15, 2026, requesting PAN ...
🟡 Board Meeting — 13 August 2026Panacea Biotec announced its August 13, 2026 board meeting outcome: approval of unaudited standalone...

See all PANACEABIO filings →

🔥 Also filed on 7 September 2026

521036Source Industries (India) LtdAnnual Report 543578Olatech Solutions LtdAnnual Report 512025Asgard Alcobev LtdAnnual Report SIGACHISigachi Industries LtdCorporate Action 503675Wagend Infra Venture LtdAnnual Report 542864Mount Housing & Infrastructure LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PANACEABIO files new disclosures

Track PANACEABIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.